mounjaro vs semaglutide weight loss vs. Tirzepatide for Semaglutide vs. Mounjaro for Weight
Description
An overactive immune response to the cell damage caused by some trypsin activation in the pancreas can increase the risk of pancreatitis

Spinal Cord Injuries & Paralysis Resulting from falls or assaults

Dual GIP/GLP-1 agonists like tirzepatide 15 mg achieve approximately 22.5% average weight loss over 72 weeks

1 Health Canada's new indication approval is based on results from the pooled analysis of SUSTAIN 6, PIONEER 6, FLOW and SOUL that demonstrated treatment with Ozempic reduced the risk of major adverse cardiovascular events (MACE) compared to placebo, when used in addition to standard of care

This is particularly important as these changes can improve your treatment adherence and persistence, ultimately leading to better overall health outcomes

Into the stomach (we will show you how to do this injection)
